Solifenacin
- Product NDC
- 70771-1604
- 11-digit product format
- 707711604
- Labeler code
- 70771
- Product ID
- 70771-1604_205b6c54-6d0b-4c07-b4b8-7a95e9456282
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Solifenacin
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Zydus Lifesciences Limited
- Application
- ANDA207721
- Marketing category
- ANDA
- Marketing start
- 2022-02-10
- Marketing end
- 0000-00-00
- Substance
- SOLIFENACIN SUCCINATE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70771-1604-3 | 70771160403 | 30 TABLET, FILM COATED in 1 BOTTLE (70771-1604-3) | 2022-02-10 | 0000-00-00 | No | No | Current |
| 70771-1604-9 | 70771160409 | 90 TABLET, FILM COATED in 1 BOTTLE (70771-1604-9) | 2022-02-10 | 0000-00-00 | No | No | Current |